The unexpected role of vitamin E (α-tocopherol) in the peroxidation of human low-density lipoprotein

Accounts of Chemical Research

Volumn 32, Issue 1, 1999, Pages 27-34

  Bowry, Vincent W ^a   Ingold, K U ^b  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; LIPID ANALYSIS; LIPID PEROXIDATION; OXIDATION REDUCTION REACTION; POLYMERIZATION;

EID: 0032955098     PISSN: 00014842     EISSN: None     Source Type: Journal    
DOI: 10.1021/ar950059o     Document Type: Article

References (79)

1. Issued as NRCC No. 0000.
2. LDL is the main "cholesterol delivery vehicle" of human blood; LDL particles carry cholesterol -mainly in the form of cholesteryl esters - from the liver to tissues throughout the body. The name derives from the flotation density of LDL in aqueous suspension (d = 1.00-1.1 g/mL) which distinguishes it from the other lipid-bearing proteins in blood and lymph, notably the high-density lipoprotein (HDLs, d > 1.15 g/mL, the "cholesterol recovery vehicle" in blood), very low-density lipoproteins (VLDLs, 0.9-1.0 g/mL), and chylomicrons.
3. Steinberg, D. P., S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. New England J. Med. 1989, 320, 915-924. Steinberg, D. Lancet 1995, 346, 36-38. Maggi, E.; Chiesa, R.; Melissano, G.; Castellano, R.; Astore, D.; Grossi, A.; Finardi, G.; Bellomo, G. Arterioscler. Thromb. 1994, 14, 1892-1899. Holvoet, P.; Collen, D. FASEB J. 1994, 8, 1279-1284. Palinski, W.; Ord, V. A.; Plump, A. S.; Breslow, J. L.; Steinberg, D.; Witztum, J. L. Arterioscler. Thromb. 1994, 14, 605-616.
4. Steinberg, D. P., S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. New England J. Med. 1989, 320, 915-924. Steinberg, D. Lancet 1995, 346, 36-38. Maggi, E.; Chiesa, R.; Melissano, G.; Castellano, R.; Astore, D.; Grossi, A.; Finardi, G.; Bellomo, G. Arterioscler. Thromb. 1994, 14, 1892-1899. Holvoet, P.; Collen, D. FASEB J. 1994, 8, 1279-1284. Palinski, W.; Ord, V. A.; Plump, A. S.; Breslow, J. L.; Steinberg, D.; Witztum, J. L. Arterioscler. Thromb. 1994, 14, 605-616.
5. Steinberg, D. P., S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. New England J. Med. 1989, 320, 915-924. Steinberg, D. Lancet 1995, 346, 36-38. Maggi, E.; Chiesa, R.; Melissano, G.; Castellano, R.; Astore, D.; Grossi, A.; Finardi, G.; Bellomo, G. Arterioscler. Thromb. 1994, 14, 1892-1899. Holvoet, P.; Collen, D. FASEB J. 1994, 8, 1279-1284. Palinski, W.; Ord, V. A.; Plump, A. S.; Breslow, J. L.; Steinberg, D.; Witztum, J. L. Arterioscler. Thromb. 1994, 14, 605-616.
6. Steinberg, D. P., S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. New England J. Med. 1989, 320, 915-924. Steinberg, D. Lancet 1995, 346, 36-38. Maggi, E.; Chiesa, R.; Melissano, G.; Castellano, R.; Astore, D.; Grossi, A.; Finardi, G.; Bellomo, G. Arterioscler. Thromb. 1994, 14, 1892-1899. Holvoet, P.; Collen, D. FASEB J. 1994, 8, 1279-1284. Palinski, W.; Ord, V. A.; Plump, A. S.; Breslow, J. L.; Steinberg, D.; Witztum, J. L. Arterioscler. Thromb. 1994, 14, 605-616.
7. Steinberg, D. P., S.; Carew, T. E.; Khoo, J. C.; Witztum, J. L. New England J. Med. 1989, 320, 915-924. Steinberg, D. Lancet 1995, 346, 36-38. Maggi, E.; Chiesa, R.; Melissano, G.; Castellano, R.; Astore, D.; Grossi, A.; Finardi, G.; Bellomo, G. Arterioscler. Thromb. 1994, 14, 1892-1899. Holvoet, P.; Collen, D. FASEB J. 1994, 8, 1279-1284. Palinski, W.; Ord, V. A.; Plump, A. S.; Breslow, J. L.; Steinberg, D.; Witztum, J. L. Arterioscler. Thromb. 1994, 14, 605-616.
8. See, e.g.: Gaziano, J. M. Am. J. Med. 1994, 97, 18S-21S. Hoffman, R. M.; Garewal, H. S. Arch. Intern. Med. 1995, 155, 241-246; Gey, K. F., Puska, P., Jordan, P.; Moser, U. K. Am. J. Clin. Nutr. 1991, 53, 326S-334S.
9. See, e.g.: Gaziano, J. M. Am. J. Med. 1994, 97, 18S-21S. Hoffman, R. M.; Garewal, H. S. Arch. Intern. Med. 1995, 155, 241-246; Gey, K. F., Puska, P., Jordan, P.; Moser, U. K. Am. J. Clin. Nutr. 1991, 53, 326S-334S.
10. See, e.g.: Gaziano, J. M. Am. J. Med. 1994, 97, 18S-21S. Hoffman, R. M.; Garewal, H. S. Arch. Intern. Med. 1995, 155, 241-246; Gey, K. F., Puska, P., Jordan, P.; Moser, U. K. Am. J. Clin. Nutr. 1991, 53, 326S-334S.
11. Sasahara, M.; Raines, E. W.; Chait, A.; Carew, T. E.; Steinberg, D.; Wahl, P. W.; Ross, R. J. Clin. Invest. 1994, 94, 155-164.
12. Review: Esterbauer, H.; Gebicki, J.; Puhl, H.; Jürgens, G. Free Radical Biol. Med. 1992, 13, 341-390.
13. Burton, G.; Ingold, K. U. Acc. Chem. Res. 1986, 19, 194-201.
14. Some reported correlations between α-TOH content and resistance of LDL to peroxidation: (Positive) Esterbauer, H.; Dieber Rotheneder, M.; Striegl, G.; Waeg, G. Am. J. Clin. Nutr. 1991, 53, 314s-321s. (Erratic or minor) McDowell, I. F. W.; Brennan, G. M.; McEneny, J.; Young, I. S.; Nicholls, D. P.; McVeigh, G. E.; Bruce, I.; Trimble, E. R.; Johnston, G. D. Eur. J. Clin. Invest. 1994, 24, 759-765. (Negative) Iwatsuki, M.; Niki, E.; Stone, D.; Darley-Usmar, V. M. FEBS Lett. 1995, 360, 271-276. Croft, K. D.; Williams, P.; Dimmitt, S.; Abu Amsha, R.; Beilin, L. J. Biochim. Biophys. Acta 1995, 1254, 250-256.
15. Some reported correlations between α-TOH content and resistance of LDL to peroxidation: (Positive) Esterbauer, H.; Dieber Rotheneder, M.; Striegl, G.; Waeg, G. Am. J. Clin. Nutr. 1991, 53, 314s-321s. (Erratic or minor) McDowell, I. F. W.; Brennan, G. M.; McEneny, J.; Young, I. S.; Nicholls, D. P.; McVeigh, G. E.; Bruce, I.; Trimble, E. R.; Johnston, G. D. Eur. J. Clin. Invest. 1994, 24, 759-765. (Negative) Iwatsuki, M.; Niki, E.; Stone, D.; Darley-Usmar, V. M. FEBS Lett. 1995, 360, 271-276. Croft, K. D.; Williams, P.; Dimmitt, S.; Abu Amsha, R.; Beilin, L. J. Biochim. Biophys. Acta 1995, 1254, 250-256.
16. Some reported correlations between α-TOH content and resistance of LDL to peroxidation: (Positive) Esterbauer, H.; Dieber Rotheneder, M.; Striegl, G.; Waeg, G. Am. J. Clin. Nutr. 1991, 53, 314s-321s. (Erratic or minor) McDowell, I. F. W.; Brennan, G. M.; McEneny, J.; Young, I. S.; Nicholls, D. P.; McVeigh, G. E.; Bruce, I.; Trimble, E. R.; Johnston, G. D. Eur. J. Clin. Invest. 1994, 24, 759-765. (Negative) Iwatsuki, M.; Niki, E.; Stone, D.; Darley-Usmar, V. M. FEBS Lett. 1995, 360, 271-276. Croft, K. D.; Williams, P.; Dimmitt, S.; Abu Amsha, R.; Beilin, L. J. Biochim. Biophys. Acta 1995, 1254, 250-256.
17. Some reported correlations between α-TOH content and resistance of LDL to peroxidation: (Positive) Esterbauer, H.; Dieber Rotheneder, M.; Striegl, G.; Waeg, G. Am. J. Clin. Nutr. 1991, 53, 314s-321s. (Erratic or minor) McDowell, I. F. W.; Brennan, G. M.; McEneny, J.; Young, I. S.; Nicholls, D. P.; McVeigh, G. E.; Bruce, I.; Trimble, E. R.; Johnston, G. D. Eur. J. Clin. Invest. 1994, 24, 759-765. (Negative) Iwatsuki, M.; Niki, E.; Stone, D.; Darley-Usmar, V. M. FEBS Lett. 1995, 360, 271-276. Croft, K. D.; Williams, P.; Dimmitt, S.; Abu Amsha, R.; Beilin, L. J. Biochim. Biophys. Acta 1995, 1254, 250-256.
18. Ingold, K. U.; Bowry, V. W.; Stocker, R.; Walling, C. Proc. Nat. Acad. Sci. U.S.A. 1993, 90, 45-49.
19. Neuzil, J.; Thomas, S. R.; Stocker, R. Free Radical Biol. Med. 1997, 22, 57-71 and cited references.
20. Bowry, V. W.; Ingold, K. U.; Stocker, R. Biochem. J. 1992, 288, 341-344.
21. Bowry, V. W.; Mohr, D.; Cleary, J.; Stocker, R. J. Biol. Chem. 1995, 270, 5756-5763.
22. Witting, P. K.; Bowry, V. W.; Stocker, R. FEBS Lett. 1995, 375, 45-49.
23. Where LH refers to a bisallylic group in a polyunsaturated fatty acid ester (phospholipid, triglyceride, cholesterol ester, etc.), L• and LOO• are the derived carbon-centered radical and lipid peroxyl radical, respectively, and ROO• is the peroxyl radical which initiates lipid peroxidation.
24. Burton, G. W.; Doba, T.; Gabe, E.; Hughes, L.; Lee, F. L.; Prasad, L.; Ingold, K. U. J. Am. Chem. Soc. 1985, 107, 7053-7065.
25. Niki, E.; Saito, M.; Kawakami, A.; Kamiya, Y. J. Biol. Chem. 1984, 259, 4177-4182.
26. Avila, D. V.; Brown, C. E., Ingold, K. U.; Lusztyk, J. J. Am. Chem. Soc. 1993, 115, 466-470.
27. Valgimigli, L.; Banks, J. T.; Ingold, K. U.; Lusztyk, J. J. Am. Chem. Soc. 1995, 117, 9966-9971. Valgimigli, L.; Ingold, K. U.; Lusztyk, J. J. Org. Chem. 1996, 61, 7947-7950.
28. Valgimigli, L.; Banks, J. T.; Ingold, K. U.; Lusztyk, J. J. Am. Chem. Soc. 1995, 117, 9966-9971. Valgimigli, L.; Ingold, K. U.; Lusztyk, J. J. Org. Chem. 1996, 61, 7947-7950.
29. Avila, D. V.; Ingold, K. U.; Lusztyk, J.; Green, W. H.; Procopio, D. R. J. Am. Chem. Soc. 1995, 117, 2929-2930.
30. MacFaul, P. A.; Ingold, K. U.; Lusztyk, J. J. Am. Chem. Soc. 1996, 118, 1316-1321.
31. Castle, L.; Perkins, M. J. J. Am. Chem. Soc. 1986, 108, 6381-6382. Pryor, W. A.; Strickland, T.; Church, D. F. J. Am. Chem. Soc. 1988, 110, 2224-2229.
32. Castle, L.; Perkins, M. J. J. Am. Chem. Soc. 1986, 108, 6381-6382. Pryor, W. A.; Strickland, T.; Church, D. F. J. Am. Chem. Soc. 1988, 110, 2224-2229.
33. Barclay, L. R. C.; Baskin, K. A.; Locke, S. J.; Vindquist, M. R. Can. J. Chem. 1990, 68, 2258-2269.
34. Valgimigli, L.; Ingold, K. U.; Lusztyk, J. J. Am. Chem. Soc. 1996, 118, 3545-3549.
35. p = 170 (inhibition) vs 3800 (peroxyl clock).
36. Barclay, L. R. C.; Vinqvist, M. R.; Antunes, F.; Pinto, R. E. J. Am. Chem. Soc. 1997, 119, 5764-5765.
37. Bowry, V. W.; Stocker, R. J. Am. Chem. Soc. 1993, 115, 6029-6044.
38. Sattler, W.; Kostner, G. M.; Waeg, G.; Esterbauer, H. Biochim. Biophys. Acta 1991, 1081, 65-74.
39. Carotenoids - which give LDL its yellow-orange color - do not inhibit peroxidation in LDL. Gaziano, J. M.; Hatta, A.; Flynn, M.; Johnson, E. J.; Krinsky, N. I.; Ridker, P. M.; Hennekens, C. H.; Frei, B. Atherosclerosis 1995, 112, 187-195.
40. 8 (LOO• + α-TO•).
41. Bowry, V. W.; Stanley, K. K.; Stocker, R. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 10316-10320.
42. Howard, J. A.; Ingold, K. U. Can. J. Chem. 1967, 45, 793-802.
43. See, e.g.: Esterbauer, H.; Striegl, G.; Puhl, H.; Rotheneder, M. Free Radical Res. Commun. 1989, 6, 67-75.
44. Stocker, R.; Barsamian, S.; Frei, B. Free Radical Biol. Med. 1990, 9S, 71.
45. Sato, K.; Niki, E.; Shimasaki, H. Arch. Biochem. Biophys. 1990, 279, 405-409.
46. Stocker, R.; Bowry, V. W.; Frei, B. Proc. Natl. Acad. Sci. US.A. 1991, 88, 1646-1660.
47. 2 into ubiquinone-10 (CoQ).
48. Barclay, L. R. C.; Vinqvist, M. R.; Mukai, K.; Itoh, S.; Morimoto, H. J. Org. Chem. 1993, 58, 7416-7420.
49. Doba, T.; Burton, G. W.; Ingold, K. U. Biochim. Biophys. Acta 1985, 835, 298-303.
50. That is, not until over 85% of the original α-TOH had been consumed, at which point many of the particles would be left unprotected.
51. Bowry, V. W.; Ingold, K. U. J. Org. Chem. 1995, 60, 5456-5467.
52. Massey, J. B. Biochim. Biophys. Acta 1984, 793, 387-392.
53. 41 and that of α-TO• may be even longer because it lacks the hydrophilic OH group.
54. With the simplest case assumption that particles are uniformly likely to react with the initiating ROO•.
55. polymer'/monomer.
56. Walling, C. W. Free Radicals in Solution; Wiley: New York, 1957.
57. intraparticle = 1 molecule/particle volume ≈ 0.5 mM.
58. Reference 26 gives a more exact analysis.
59. Neuzil, J.; Stocker, R. J. Biol. Chem. 1994, 269, 16712-16719.
60. Doba, T.; Burton, G. W.; Ingold, K. U.; Matsuo, M. J. Chem. Soc., Chem. Commun. 1984, 461-462.
61. Simic, M. G.; Jovanivic, S. V. J. Am. Chem. Soc. 1989, 111, 5778-5782.
62. 0.5 relationship has been confirmed for some compounds.
63. Neuzil, J.; Thomas, S. R.; Stocker, R. Free Radical Biol. Med. 1997, 22, 57-71.
64. Burton, G. W.; Ingold, K. U. J. Am. Chem. Soc. 1981, 103, 6472-6477.
65. 2O-washed reaction mixture and vice versa.
66. 2O-LDL, presumably because of the lower phasetransfer activity of α-TOD.
67. See, e.g.: (a) Abuja, P. M.; Albertini, R.; Esterbauer, H. Chem. Res. Toxicol. 1997, 10, 644-651.
68. (b) Proudfoot, J. M.; Croft, K. D.; Puddey, I. B.; Beilin, L. I. Free Radical Biol. Med. 1997, 23, 720-728.
69. Gieseg, S. P.; Esterbauer, H. FEBS Lett. 1994, 343, 188-194.
70. See: Yoshida, Y.; Tsuchiya, J.; Niki, E. Biochim. Biophys. Acta 1994, 1200, 85-92. Lynch, S. M.; Frei, B. J. Biol. Chem. 1995, 270, 5158-5163. Kontush, A.; Meyer, S.; Finckh, B.; Kohlschutter, A.; Beisiegel, U. J. Biol. Chem. 1996, 271, 11106-11112.
71. See: Yoshida, Y.; Tsuchiya, J.; Niki, E. Biochim. Biophys. Acta 1994, 1200, 85-92. Lynch, S. M.; Frei, B. J. Biol. Chem. 1995, 270, 5158-5163. Kontush, A.; Meyer, S.; Finckh, B.; Kohlschutter, A.; Beisiegel, U. J. Biol. Chem. 1996, 271, 11106-11112.
72. See: Yoshida, Y.; Tsuchiya, J.; Niki, E. Biochim. Biophys. Acta 1994, 1200, 85-92. Lynch, S. M.; Frei, B. J. Biol. Chem. 1995, 270, 5158-5163. Kontush, A.; Meyer, S.; Finckh, B.; Kohlschutter, A.; Beisiegel, U. J. Biol. Chem. 1996, 271, 11106-11112.
73. 2 = 0.043 (Figure 14 in ref 6).
74. p being independent of the initiation rate.
75. Reviewed in Berliner, J. A.; Heinecke, J. W. Free Radical Biol. Med. 1996, 20, 707-727.
76. Suarna, C.; Dean, R. T.; May, J.; Stocker, R. Arterioscler. Thromb. 1995, 15, 1616-1624.
77. Leeuwenburgh, C.; Rasmussen, J. E.; Hsu, F. F.; Mueller, D. M.; Pennathur, S.; Heinecke, J. W. J. Biol. Chem. 1997, 272, 3520-3526. Hazell, L. J.; Van Den Berg, J. J. M.; Stocker, R. Biochem. J. 1994, 302, 297-304.
78. Leeuwenburgh, C.; Rasmussen, J. E.; Hsu, F. F.; Mueller, D. M.; Pennathur, S.; Heinecke, J. W. J. Biol. Chem. 1997, 272, 3520-3526. Hazell, L. J.; Van Den Berg, J. J. M.; Stocker, R. Biochem. J. 1994, 302, 297-304.
79. Savenkova, M. I.; Mueller, D. M.; Heinecke, J. W. J. Biol. Chem. 1994, 269, 20394-20400.